BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1044 related articles for article (PubMed ID: 15126151)

  • 1. Frequency doubling technology perimetry abnormalities as predictors of glaucomatous visual field loss.
    Medeiros FA; Sample PA; Weinreb RN
    Am J Ophthalmol; 2004 May; 137(5):863-71. PubMed ID: 15126151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of frequency-doubling technology for perimetrically normal eyes of open-angle glaucoma patients with unilateral field loss.
    Fan X; Wu LL; Ma ZZ; Xiao GG; Liu F
    Ophthalmology; 2010 Aug; 117(8):1530-7, 1537.e1-2. PubMed ID: 20466428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corneal thickness measurements and frequency doubling technology perimetry abnormalities in ocular hypertensive eyes.
    Medeiros FA; Sample PA; Weinreb RN
    Ophthalmology; 2003 Oct; 110(10):1903-8. PubMed ID: 14522761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glaucomatous visual field progression with frequency-doubling technology and standard automated perimetry in a longitudinal prospective study.
    Haymes SA; Hutchison DM; McCormick TA; Varma DK; Nicolela MT; LeBlanc RP; Chauhan BC
    Invest Ophthalmol Vis Sci; 2005 Feb; 46(2):547-54. PubMed ID: 15671281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of SITA and full-threshold standard perimetry to frequency-doubling technology perimetry in glaucoma.
    Boden C; Pascual J; Medeiros FA; Aihara M; Weinreb RN; Sample PA
    Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2433-9. PubMed ID: 15980232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency-doubling technology perimetry for detection of the development of visual field defects in glaucoma suspect eyes: a prospective study.
    Liu S; Yu M; Weinreb RN; Lai G; Lam DS; Leung CK
    JAMA Ophthalmol; 2014 Jan; 132(1):77-83. PubMed ID: 24177945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency doubling technology perimetry in open-angle glaucoma eyes with hemifield visual field damage: comparison of high-tension and normal-tension groups.
    Murata H; Tomidokoro A; Matsuo H; Tomita G; Araie M
    J Glaucoma; 2007 Jan; 16(1):9-13. PubMed ID: 17224743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visual function-specific perimetry for indirect comparison of different ganglion cell populations in glaucoma.
    Sample PA; Bosworth CF; Blumenthal EZ; Girkin C; Weinreb RN
    Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1783-90. PubMed ID: 10845599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between Humphrey 30-2 SITA Standard Test, Matrix 30-2 threshold test, and Heidelberg retina tomograph in ocular hypertensive and glaucoma patients.
    Bozkurt B; Yilmaz PT; Irkec M
    J Glaucoma; 2008; 17(3):203-10. PubMed ID: 18414106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can frequency-doubling technology and short-wavelength automated perimetries detect visual field defects before standard automated perimetry in patients with preperimetric glaucoma?
    Ferreras A; Polo V; Larrosa JM; Pablo LE; Pajarin AB; Pueyo V; Honrubia FM
    J Glaucoma; 2007; 16(4):372-83. PubMed ID: 17571000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variability components of standard automated perimetry and frequency-doubling technology perimetry.
    Spry PG; Johnson CA; McKendrick AM; Turpin A
    Invest Ophthalmol Vis Sci; 2001 May; 42(6):1404-10. PubMed ID: 11328758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of frequency-doubling technology perimetry in a population-based prevalence survey of glaucoma: the Tajimi study.
    Iwase A; Tomidokoro A; Araie M; Shirato S; Shimizu H; Kitazawa Y;
    Ophthalmology; 2007 Jan; 114(1):27-32. PubMed ID: 17070580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ability of short-wavelength automated perimetry to predict conversion to glaucoma.
    van der Schoot J; Reus NJ; Colen TP; Lemij HG
    Ophthalmology; 2010 Jan; 117(1):30-4. PubMed ID: 19896194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing multifocal VEP and standard automated perimetry in high-risk ocular hypertension and early glaucoma.
    Fortune B; Demirel S; Zhang X; Hood DC; Patterson E; Jamil A; Mansberger SL; Cioffi GA; Johnson CA
    Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1173-80. PubMed ID: 17325161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting progression of glaucoma from rates of frequency doubling technology perimetry change.
    Meira-Freitas D; Tatham AJ; Lisboa R; Kuang TM; Zangwill LM; Weinreb RN; Girkin CA; Liebmann JM; Medeiros FA
    Ophthalmology; 2014 Feb; 121(2):498-507. PubMed ID: 24289917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinal nerve fiber layer thickness measurements with scanning laser polarimetry predict glaucomatous visual field loss.
    Mohammadi K; Bowd C; Weinreb RN; Medeiros FA; Sample PA; Zangwill LM
    Am J Ophthalmol; 2004 Oct; 138(4):592-601. PubMed ID: 15488786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Frequency doubling perimetry in diagnosis of early glaucomatous optic nerve fiber damage].
    Korzekwa W; Korzekwa M; Markowska J; Wójcik-Niklewska B; Romaniuk W; Korzekwa A; Michalska-Małecka K
    Klin Oczna; 2004; 106(1-2 Suppl):222-4. PubMed ID: 15510506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testing for glaucoma with frequency-doubling perimetry in normals, ocular hypertensives, and glaucoma patients.
    Horn FK; Wakili N; Jünemann AM; Korth M
    Graefes Arch Clin Exp Ophthalmol; 2002 Aug; 240(8):658-65. PubMed ID: 12192460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Groningen Longitudinal Glaucoma Study. II. A prospective comparison of frequency doubling perimetry, the GDx nerve fibre analyser and standard automated perimetry in glaucoma suspect patients.
    Jansonius NM; Heeg GP
    Acta Ophthalmol; 2009 Jun; 87(4):429-32. PubMed ID: 18652580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detectability of glaucomatous changes using SAP, FDT, flicker perimetry, and OCT.
    Nomoto H; Matsumoto C; Takada S; Hashimoto S; Arimura E; Okuyama S; Shimomura Y
    J Glaucoma; 2009 Feb; 18(2):165-71. PubMed ID: 19225357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 53.